These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35773764)

  • 1. [Clinical characteristics and genetic analysis of a pedigree affected with neonatal central core disease].
    Dong X; Zheng X; Lin F; Feng L; Xiong H; Kang W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jun; 39(6):607-610. PubMed ID: 35773764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silent polymorphisms in the RYR1 gene do not modify the phenotype of the p.4898 I>T pathogenic mutation in central core disease: a case report.
    Cuperman T; Fernandes SA; Lourenço NC; Yamamoto LU; Silva HC; Pavanello RC; Yamamoto GL; Zatz M; Oliveira AS; Vainzof M
    BMC Res Notes; 2014 Aug; 7():487. PubMed ID: 25084811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic testing of a Chinese pedigree affected with non-syndromic autosomal dominant deafness 15].
    Kang H; Zhao K; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jul; 38(7):639-642. PubMed ID: 34247367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new mutation in the skeletal ryanodine receptor gene (RYR1) is potentially causative of malignant hyperthermia, central core disease, and severe skeletal malformation.
    Rueffert H; Olthoff D; Deutrich C; Schober R; Froster UG
    Am J Med Genet A; 2004 Jan; 124A(3):248-54. PubMed ID: 14708096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resistance to thyroid hormone syndrome due to p.Cys446Ser variant of THRbeta gene in a pedigree].
    Sun S; Ding Y; Kong Y; Wang F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Sep; 38(9):838-840. PubMed ID: 34487525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hot spot mutation screening of RYR1 gene in diagnosis of congenital myopathies].
    Chang XZ; Jin YW; Wang JM; Yuan Y; Xiong H; Wang S; Qin J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):691-7. PubMed ID: 25331388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel excitation-contraction uncoupled RYR1 mutations in patients with central core disease.
    Kraeva N; Zvaritch E; Rossi AE; Goonasekera SA; Zaid H; Frodis W; Kraev A; Dirksen RT; Maclennan DH; Riazi S
    Neuromuscul Disord; 2013 Feb; 23(2):120-32. PubMed ID: 23183335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of PROC gene variant in a Chinese pedigree affected with hereditary protein C deficiency].
    Chen Y; Shi J; Huang X; Sheng A; Lu C; Zhu M; Wang Q; Wang M; Wang D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1233-1237. PubMed ID: 36317209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel RYR1 missense mutations in six Chinese patients with central core disease.
    Gu M; Zhang S; Hu J; Yuan Y; Wang Z; Da Y; Wu S
    Neurosci Lett; 2014 Apr; 566():32-5. PubMed ID: 24561095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: evidence for a cluster of novel mutations in the C-terminal region.
    Galli L; Orrico A; Cozzolino S; Pietrini V; Tegazzin V; Sorrentino V
    Cell Calcium; 2002 Sep; 32(3):143-51. PubMed ID: 12208234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of a novel variant of COL4A5 gene in a pedigree affected with Alport syndrome].
    Liu X; Gao M; Zou Y; Wang L; Kang R; Xu P; Niu Y; Huang S; Li J; Xie H; Gao Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Aug; 37(8):807-810. PubMed ID: 32761583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of phenotype and FH gene variation in a pedigree affected with hereditary leiomyomatosis and renal cell carcinoma syndrome].
    Guo Y; Wang L; Xu Z; Bai Y; Wang W; Wu H; Sun Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 May; 39(5):494-498. PubMed ID: 35598264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central core disease due to recessive mutations in RYR1 gene: is it more common than described?
    Kossugue PM; Paim JF; Navarro MM; Silva HC; Pavanello RC; Gurgel-Giannetti J; Zatz M; Vainzof M
    Muscle Nerve; 2007 May; 35(5):670-4. PubMed ID: 17226826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.
    Tilgen N; Zorzato F; Halliger-Keller B; Muntoni F; Sewry C; Palmucci LM; Schneider C; Hauser E; Lehmann-Horn F; Müller CR; Treves S
    Hum Mol Genet; 2001 Dec; 10(25):2879-87. PubMed ID: 11741831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parental mosaicism in RYR1-related Central Core Disease.
    Marks S; van Ruitenbeek E; Fallon P; Johns P; Phadke R; Mein R; Mohammed S; Jungbluth H
    Neuromuscul Disord; 2018 May; 28(5):422-426. PubMed ID: 29576327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene.
    Davis MR; Haan E; Jungbluth H; Sewry C; North K; Muntoni F; Kuntzer T; Lamont P; Bankier A; Tomlinson P; Sánchez A; Walsh P; Nagarajan L; Oley C; Colley A; Gedeon A; Quinlivan R; Dixon J; James D; Müller CR; Laing NG
    Neuromuscul Disord; 2003 Feb; 13(2):151-7. PubMed ID: 12565913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central core disease is due to RYR1 mutations in more than 90% of patients.
    Wu S; Ibarra MC; Malicdan MC; Murayama K; Ichihara Y; Kikuchi H; Nonaka I; Noguchi S; Hayashi YK; Nishino I
    Brain; 2006 Jun; 129(Pt 6):1470-80. PubMed ID: 16621918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of genetic variants in a pedigree affected with hereditary multiple osteochondroma].
    Guo X; Zheng Q; Lin M; Zhang Y; Shi T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Jun; 38(6):549-552. PubMed ID: 34096023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.